Feasibility of tongue strength measurements during (chemo)radiotherapy in head and neck cancer patients.

Van den Steen, Leen;Vanderveken, Olivier;Vanderwegen, Jan;Van Gestel, Dirk;Van Nuffelen, Gwen;et.al.
(2017) Supportive Care in Cancer — Vol. 25, n° 11, p. 3417-3423 (2017)

Files

VandenSteenLSupportCareCancer2017.pdf
  • Restricted Access
  • Adobe PDF
  • 770.76 KB

Details

Authors
  • Van den Steen, Leen
    Author
  • Vanderveken, Olivier
    Author
  • Vanderwegen, Jan
    Author
  • Van Gestel, Dirk
    Author
  • Daisne, Jean-FrançoisUCLouvain
    Author
  • Delacroix, LaurenceUCLouvain
    Author
  • Desuter, GauthierUCLouvain
    Author
  • Lawson, GeorgesUCLouvain
    Author
  • Van Nuffelen, Gwen
    Author
Show more
Abstract
(en) PURPOSE: The aim of this study was to investigate the feasibility of tongue strength measures (TSMs) and the influence of bulb location, sex, and self-perceived pain and mucositis in head and neck cancer (HNC) patients during chemoradiotherapy (CRT). METHODS: Twenty-six newly diagnosed HNC patients treated with CRT performed anterior and posterior maximal isometric tongue pressures by means of the Iowa Oral Performance Instrument (IOPI). The Oral Mucositis Weekly Questionnaire (OMWQ) and a Visual Analogue Scale (VAS) for pain during swallowing were completed weekly from baseline to 1 week post CRT. RESULTS: Feasibility of TSMs during CRT declines significantly from 96 to 100% at baseline to 46% after 6 weeks of CRT. But post-hoc analyses reveal only significant differences in feasibility between baseline and measurements after 4 weeks of treatment. No effect of gender or bulb location was established, but feasibility is influenced by pain and mucositis. CONCLUSIONS: Feasibility of TSMs declines during CRT and is influenced by mucositis and pain. For the majority of subjects, TSMs were feasible within the first 4 weeks, which provides a window of scientific and clinical opportunities in this patient population.
Affiliations

Citations

Van den Steen, L., Vanderveken, O., Vanderwegen, J., Van Gestel, D., Daisne, J.-F., Allouche, J., Delacroix, L., Van Rompaey, D., Beauvois, S., Cvilic, S., Mariën, S., Desuter, G., Vermorken, J. B., Van den Weyngaert, D., Specenier, P., Van Laer, C., Peeters, M., Van de Heyning, P., Chantrain, G., et al. (2017). Feasibility of tongue strength measurements during (chemo)radiotherapy in head and neck cancer patients. Supportive Care in Cancer, 25(11), 3417-3423. https://doi.org/10.1007/s00520-017-3761-1 (Original work published 2017)